RAPID: A regional plan to rescue the orphaned University of Louisiana Monroe Fish Collection Read more about RAPID: A regional plan to rescue the orphaned University of Louisiana Monroe Fish Collection
Digitization TCN Collaborative Research: The Key to the Cabinets. Building and Sustaining a Research Database for Global biodiversity Read more about Digitization TCN Collaborative Research: The Key to the Cabinets. Building and Sustaining a Research Database for Global biodiversity
CSBR: Ownership Transfer: A regional plan to rescue the orphaned University of Louisiana Monroe Fish Collection Read more about CSBR: Ownership Transfer: A regional plan to rescue the orphaned University of Louisiana Monroe Fish Collection
Procurement of Blood Samples from Subjects with Diagnosed Nonalcoholic Steatohepatitis or Nonalcoholic Fatty Liver for use in the Development of a Liver Fibrosis Test Read more about Procurement of Blood Samples from Subjects with Diagnosed Nonalcoholic Steatohepatitis or Nonalcoholic Fatty Liver for use in the Development of a Liver Fibrosis Test
Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH Read more about Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH
Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH Read more about Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH
Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH Read more about Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH
Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH Read more about Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH
Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH Read more about Open-Label Rollover Study of Cenicrivoc for the Treatment of Liver Fibrosis in Adult Subjects with NASH
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate Safety, Tolerability and Pharmacodynamics of PF-05221304 Administered Daily for 16 Weeks... Read more about A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate Safety, Tolerability and Pharmacodynamics of PF-05221304 Administered Daily for 16 Weeks...
